Birzeit Pharmaceuticals Company - Neraca (Quarterly)

Birzeit Pharmaceuticals Company
PS ˙ PLSE
Talaan ng Balanse (Quarterly)

Neraca Birzeit Pharmaceuticals Company menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 3 4 4 1 1 2 4 3 3 3 4 2 3 2 1 1 3 1 2
Change (%) 64.08 -12.44 -61.88 -18.82 61.15 140.52 -31.88 0.05 0.24 23.09 -38.58 36.92 -41.57 -52.91 60.05 124.21 -51.36 15.08
Assets Current 50 52 58 59 60 63 66 66 68 71 68 64 67 66 65 66 70 59 65
Change (%) 3.79 11.12 2.01 1.12 5.83 4.81 -0.86 4.06 3.78 -3.70 -5.85 4.66 -2.48 -0.65 2.05 5.47 -15.97 9.60
Assets 99 101 109 111 112 116 116 116 123 127 125 125 125 121 120 122 129 123 132
Change (%) 1.86 7.76 1.66 1.30 3.35 0.65 -0.28 5.90 2.99 -1.29 -0.41 0.49 -3.34 -0.45 0.90 6.02 -4.13 6.48
Liabilities 19 20 23 21 19 20 19 17 19 20 21 17 20 20 21 22 24 21 23
Change (%) 4.84 14.25 -8.79 -9.17 2.31 -1.57 -10.81 13.13 2.77 3.01 -17.10 17.64 -0.74 7.35 1.74 9.74 -11.48 6.85
Equity 80 81 86 89 93 96 97 99 104 107 104 107 105 101 99 100 105 102 109
Change (%) 1.14 6.13 4.48 3.77 3.56 1.11 1.81 4.64 3.03 -2.10 2.89 -2.24 -3.84 -1.99 0.72 5.20 -2.45 6.40
Liabilities And Stock Equity 99 101 109 111 112 116 116 116 123 127 125 125 125 121 120 122 129 123 132
Change (%) 1.86 7.76 1.66 1.30 3.35 0.65 -0.28 5.90 2.99 -1.29 -0.41 0.49 -3.34 -0.45 0.90 6.02 -4.13 6.48

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista